ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

TNXP Tonix Pharmaceuticals Holding Corporation

0.17
0.01005 (6.28%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01005 6.28% 0.17 08:50:13
始値 安値 高値 終値 前日終値
0.16 0.1597 0.1703 0.1685 0.15995
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2421:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
2024/4/0205:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/3/2822:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
2024/3/2521:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
2024/3/2121:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
2024/3/2021:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
2024/3/1921:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
2024/3/1221:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
2024/3/1121:05EDGAR2Form 8-K - Current report
2024/3/1121:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
2024/3/0723:37GLOBENew to The Street Announces TV Episode 560 with its Five..
2024/3/0722:06EDGAR2Form 8-K - Current report
2024/3/0722:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
2024/3/0707:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2024/3/0622:05EDGAR2Form 8-K - Current report
2024/3/0622:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
2024/3/0522:05EDGAR2Form 8-K - Current report
2024/3/0522:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
2024/3/0107:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2922:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
2024/2/2822:06EDGAR2Form 8-K - Current report
2024/2/2822:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
2024/2/2722:07EDGAR2Form 8-K - Current report
2024/2/2722:00GLOBETonix Pharmaceuticals Announces Positive Results from..
2024/2/2323:30GLOBENew to The Street Announces Line-up of its Corporate..
2024/2/2022:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
2024/2/1623:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
2024/2/1607:02EDGAR2Form 8-K - Current report
2024/2/1505:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1422:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
2024/2/1322:05EDGAR2Form 8-K - Current report
2024/2/1322:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
2024/2/1222:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
2024/2/1221:06EDGAR2Form 8-K - Current report
2024/1/3121:05EDGAR2Form 8-K - Current report
2024/1/3121:00GLOBETonix Pharmaceuticals Announces Research Indicating..
2024/1/2921:00EDGAR2Form 8-K - Current report
2024/1/2921:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
2024/1/2606:08EDGAR2Form 8-K - Current report
2024/1/2521:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
2024/1/2006:31EDGAR2Form 8-K - Current report
2024/1/1206:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0921:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
2024/1/0907:07EDGAR2Form 8-K - Current report
2024/1/0906:33EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/0406:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0321:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..

最近閲覧した銘柄

Delayed Upgrade Clock